Transfemoral Transcatheter Aortic Valve Replacement in a Patient With Heparin-Induced Thrombocytopenia: Intraoperative Anticoagulation Management With Bivalirudin (Angiomax).

@article{Scott2015TransfemoralTA,
  title={Transfemoral Transcatheter Aortic Valve Replacement in a Patient With Heparin-Induced Thrombocytopenia: Intraoperative Anticoagulation Management With Bivalirudin (Angiomax).},
  author={Bharathi H. Scott and Christopher W. F. Tam and Roger S. Moon},
  journal={Journal of cardiothoracic and vascular anesthesia},
  year={2015},
  volume={29 6},
  pages={
          1603-5
        }
}
From the *State University of New York at Stony Brook, Stony Brook University Hospital; and †New York Hospital, NY, Stony Brook, NY. Address reprint requests to Bharathi Scott, MD, State University of New York at Stony Brook, Stony Brook University Hospital, 100 Nichols Road, Stony Brook, NY 11784. E-mail: scott@stonybrookmedicine.edu © 2015 Elsevier Inc. All rights reserved. 1053-0770/2602-0033$36.00/0 http://dx.doi.org/10.1053/j.jvca.2014.10.018 
BETA

Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Systematic review and metaanalysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis

C Cao, CA Su, TD Yan
  • Ann Cardiothorac Surg 2(1):10-13,
  • 2013
VIEW 1 EXCERPT

Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients.

  • EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • 2012
VIEW 1 EXCERPT

Bivalirudin

E Warkentin, A Greinacher, A Koster
  • Thrombosis and haemostasis
  • 2008

Similar Papers

Loading similar papers…